Sector Experience
Experience
Selected Contributions:
• Introduced novel stock-and-flow model that correlates tumor biology with commercial viability
• Revamped evaluation process for post-LOE assets in US and EU given the changing biosimilar space
Selected Contributions:
• Directed three industry reports receiving prestigious internal award for most differentiated research and thought leadership. Reduced data analysis time by 80% through the use of templates.